Selective M1 muscarinic agonists: failure of therapeutic strategy against Alzheimer’s disease or inappropriate tactics?
Loss of sigma binding sites in the CA1 area of the anterior hippocampus in Alzheimer’s disease correlates with CA1 pyramidal cell loss.